Icon

bioMérieux S.A Stock Analysis and Price Target COMMON STOCK | Diagnostics & Research | OTC

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 108.61

0.00 (0.00)%

USD 12.37B

N/A

N/A

N/A

Icon

BMXMF

bioMérieux S.A (USD)
COMMON STOCK | OTC
USD 108.61
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 12.37B

N/A

USD 108.61

bioMérieux S.A Stock Forecast

N/A

Based on the bioMérieux S.A stock forecast from 0 analysts, the average analyst target price for bioMérieux S.A is not available over the next 12 months. bioMérieux S.A’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of bioMérieux S.A is Neutral, which is based on 8 positive signals and 8 negative signals. At the last closing, bioMérieux S.A’s stock price was USD 108.61. bioMérieux S.A’s stock price has changed by +3.69% over the past week, +18.54% over the past month and +10.49% over the last year.

No recent analyst target price found for bioMérieux S.A
No recent average analyst rating found for bioMérieux S.A

Company Overview bioMérieux S.A

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the...Read More

https://www.biomerieux.com

376 Chemin De l?Orme, Marcy l'Étoile, France, 69280

12,557

December

USD

USA

Adjusted Closing Price for bioMérieux S.A (BMXMF)

Loading...

Unadjusted Closing Price for bioMérieux S.A (BMXMF)

Loading...

Share Trading Volume for bioMérieux S.A Shares

Loading...

Compare Performance of bioMérieux S.A Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BMXMF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To bioMérieux S.A (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WUXIF
WuXi AppTec Co. Ltd 0.00 (0.00%) USD35.02B 27.58 3.01

ETFs Containing BMXMF

Symbol Name BMXMF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About bioMérieux S.A (BMXMF) Stock

Stock Target Advisor's fundamental analysis for bioMérieux S.A's stock is Neutral.

BMXMF stock's dividend yield is 0.87%. Our analysis grades BMXMF stock's dividend yield at F. This means that BMXMF stock's dividend yield is above 8% of the stocks in the Diagnostics & Research sector in the OTC exchange. Based on this BMXMF may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on BMXMF's stock to indicate what its average analyst target is.

BMXMF stock's Price/Earning ratio is 29.42. Our analysis grades BMXMF stock's Price / Earning ratio at F. This means that BMXMF stock's Price/Earning ratio is above 78% of the stocks in the Diagnostics & Research sector in the OTC exchange. Based on this BMXMF may be a overvalued for its sector.

The last closing price of BMXMF's stock was USD 108.61.

The most recent market capitalization for BMXMF is USD 12.37B.

Unfortunately we do not have enough analyst data on BMXMF's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...